Constitutional telomerase mutations are genetic risk factors for cirrhosis
暂无分享,去创建一个
S. Chanock | N. Young | M. Zago | R. Calado | T. Boyer | Colin O. Wu | Joseph Kovacs | Paulomi M. Mehta | Jennifer N. Brudno
[1] Wei Zheng,et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33 , 2010, Nature Genetics.
[2] N. Young,et al. Telomere diseases. , 2009, The New England journal of medicine.
[3] S. Chanock,et al. A Spectrum of Severe Familial Liver Disorders Associate with Telomerase Mutations , 2009, PloS one.
[4] Qing Lan,et al. Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility. , 2009, Lung cancer.
[5] T. Vulliamy,et al. Defining the pathogenic role of telomerase mutations in myelodysplastic syndrome and acute myeloid leukemia , 2009, Human mutation.
[6] Melissa Bondy,et al. Genome-wide association study identifies five susceptibility loci for glioma , 2009, Nature Genetics.
[7] Paolo Vineis,et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types , 2009, Nature Genetics.
[8] E. Estey,et al. Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia , 2009, Proceedings of the National Academy of Sciences.
[9] Edward A Belongia,et al. National Institutes of Health Consensus Development Conference Statement: management of hepatitis B. , 2009, Annals of internal medicine.
[10] Simon Heath,et al. Lung cancer susceptibility locus at 5p15.33 , 2008, Nature Genetics.
[11] P. Lansdorp,et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis , 2008, Proceedings of the National Academy of Sciences.
[12] N. Young,et al. Telomere maintenance and human bone marrow failure. , 2008, Blood.
[13] Detlef Schuppan,et al. Liver cirrhosis , 2008, The Lancet.
[14] M. Blasco,et al. Telomere length, stem cells and aging. , 2007, Nature chemical biology.
[15] 邓伟平,et al. Dyskeratosis congenita , 2007 .
[16] Chao Xing,et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase , 2007, Proceedings of the National Academy of Sciences.
[17] N. Bache,et al. Protein Composition of Catalytically Active Human Telomerase from Immortal Cells , 2007, Science.
[18] P. Lansdorp,et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. , 2007, The New England journal of medicine.
[19] N. Samani,et al. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study , 2007, The Lancet.
[20] Olivia T. Abar,et al. Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C. , 2006, Gastroenterology.
[21] Margaret A. Strong,et al. Short Telomeres, even in the Presence of Telomerase, Limit Tissue Renewal Capacity , 2005, Cell.
[22] E. Keeffe,et al. Keratins as susceptibility genes for end-stage liver disease. , 2005, Gastroenterology.
[23] E. Blackburn,et al. Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita. , 2005, Blood.
[24] S. Chanock,et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. , 2005, The New England journal of medicine.
[25] T. Vulliamy,et al. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC , 2004, Nature Genetics.
[26] J. Satsangi,et al. Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP‐2, with outcome of HCV infection , 2003, Hepatology.
[27] P. Lansdorp,et al. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA , 2003, The Lancet.
[28] A. Bosserhoff,et al. A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. , 2003, Gastroenterology.
[29] J. Ivanovich,et al. Human telomerase RNA mutations and bone marrow failure , 2003, The Lancet.
[30] D. Brenner,et al. Genetic polymorphisms and the progression of liver fibrosis: A critical appraisal , 2003, Hepatology.
[31] J. Hoofnagle,et al. National institutes of health consensus development conference statement: Management of hepatitis C: 2002 — June 10–12, 2002 , 2002, Gastroenterology.
[32] M. Manns,et al. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis , 2002 .
[33] T. Vulliamy,et al. Association between aplastic anaemia and mutations in telomerase RNA , 2002, The Lancet.
[34] R. Cawthon. Telomere measurement by quantitative PCR. , 2002, Nucleic acids research.
[35] T. Vulliamy,et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita , 2001, Nature.
[36] E. Blackburn. Switching and Signaling at the Telomere , 2001, Cell.
[37] J. Satsangi,et al. A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. , 2001, Gastroenterology.
[38] Z. Goodman,et al. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c. , 2001, Journal of hepatology.
[39] D. Valla,et al. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. , 2001, The New England journal of medicine.
[40] G. Davis,et al. Impact of interferon alfa‐2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C , 2000, Hepatology.
[41] I. Dokal,et al. Dyskeratosis congenita in all its forms , 2000, British journal of haematology.
[42] M. Sata,et al. Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy , 2000, Annals of Internal Medicine.
[43] R. DePinho,et al. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. , 2000, Science.
[44] M. Kaplan,et al. Regression of Hepatic Fibrosis in Hepatitis C with Long-Term Interferon Treatment , 1998, Digestive Diseases and Sciences.
[45] H. Esperou,et al. Unusual complications after bone marrow transplantation for dyskeratosis congenita , 1998, British journal of haematology.
[46] S. Klauck,et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions , 1998, Nature Genetics.
[47] M. Kaplan,et al. Reversibility of Hepatic Fibrosis in Autoimmune Hepatitis , 1997, Annals of Internal Medicine.
[48] Eugene R. Schiff,et al. National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C , 1997, Hepatology.
[49] T R Hughes,et al. Reverse transcriptase motifs in the catalytic subunit of telomerase. , 1997, Science.
[50] S. Seki,et al. Telomere shortening in chronic liver diseases. , 1995, Biochemical and Biophysical Research Communications - BBRC.
[51] Carol W. Greider,et al. Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.
[52] S. Kojima,et al. Mutations in telomerase catalytic protein in Japanese children with aplastic anemia. , 2006, Haematologica.
[53] I. Dokal,et al. Dyskeratosis congenita. , 2006, Seminars in hematology.
[54] A. Olovnikov. [Principle of marginotomy in template synthesis of polynucleotides]. , 1971, Doklady Akademii nauk SSSR.
[55] Olovnikov Am. Principle of marginotomy in template synthesis of polynucleotides , 1971 .